Comparing fexuprazan and rabeprazole for treating peptic ulcer: A multicenter, randomized controlled trial

Table 3 Ulcer healing rates by Helicobacter pylori status at week 4 and week 8 (per protocol set), n (%)

Healed patients	H. pylori negative (n = 47)			H. pylori positive (n = 55)
	Fexuprazan 40 mg (n = 27)	Rabeprazole 20 mg (n = 20)	P value1	Fexuprazan 40 mg (n = 24)	Rabeprazole 20 mg (n = 31)	P value1
At 4 weeks
Yes	26 (96.30)	18 (90.00)	0.567	24 (100)	30 (96.77)	> 0.999
No	1 (3.70)	2 (10.00)		0 (0.00)	1 (3.23)
P value2						0.969
At 8 weeks
Yes	27 (100)	19 (95.00)	0.426	24 (100)	31 (100)	-
No	0 (0.00)	1 (5.00)		0 (0.00)	0 (0.00)
P value2						0.972

¹χ² test or Fisher’s exact test.

²The interaction between treatment group and Helicobacter pylori infection was assessed using logistic regression.

H. pylori: Helicobacter pylori.